Physician profile
Maryam Haque
NPI 1720235450
$1,615.69
in general payments reported to CMS, 2019-2025
16 companies · $230 in 2025
The $230 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $254 · 2023: $680 · 2024: $344 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,088 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,088.35 |
| Education | $164.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $701.40 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $257.29 | 2021-2024 | Ilumya |
| Hill Dermaceuticals, INC. | $120.45 | 2024 | Tolak |
| Ucb, INC. | $84.51 | 2022-2025 | Bimzelx |
| Amgen INC. | $78.91 | 2023-2025 | Otezla, Otezla |
| Pfizer INC. | $69.53 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $68.19 | 2023-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $55.98 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $38.59 | 2023-2024 | Sotyktu |
| Incyte Corporation | $29.32 | 2025 | Opzelura |
| Leo Pharma INC. | $28.06 | 2022 | |
| Arcutis Biotherapeutics, INC. | $21.50 | 2025 | Zoryve |
| Merz North America, INC. | $17.29 | 2025 | |
| Sandoz INC. | $16.36 | 2023 | Hyrimoz |
| Lilly USA, LLC | $14.25 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $14.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maryam Haque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.